HER2-positive gastric cancer
Clinical trials for HER2-positive gastric cancer explained in plain language.
Never miss a new study
Get alerted when new HER2-positive gastric cancer trials appear
Sign up with your email to follow new studies for HER2-positive gastric cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Triple attack on HER2-Positive stomach cancer: can chemo, targeted therapy and immunotherapy shrink tumors before surgery?
Disease control OngoingResearchers are testing whether combining FLOT chemotherapy, trastuzumab and toripalimab before and after surgery helps people with HER2-positive stomach or esophagogastric junction cancer. The trial enrolls about 30 adults with locally advanced, operable tumors. Participants rec…
Matched conditions: HER2-POSITIVE GASTRIC CANCER
Phase 2 • Sponsor: Yu jiren • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New drug cocktail targets Hard-to-Treat HER2 cancers
Disease control OngoingThis early-stage trial is testing a new drug called ELVN-002 in combination with trastuzumab and chemotherapy for people with advanced HER2-positive solid tumors, including breast, gastric, and colorectal cancers. The main goal is to find a safe dose and understand side effects. …
Matched conditions: HER2-POSITIVE GASTRIC CANCER
Phase 1 • Sponsor: Enliven Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC